304 related articles for article (PubMed ID: 17761202)
1. [Mucoepidermoid carcinoma of salivary glands: the prognostic value of tumoral markers].
Hoyek-Gebeily J; Nehmé E; Aftimos G; Sader-Ghorra C; Sargi Z; Haddad A
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):482-8. PubMed ID: 17761202
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of EGFR, p53 and E-cadherin in mucoepidermoid cancer of the salivary glands: a retrospective case series.
Hoyek-Gebeily J; Nehmé E; Aftimos G; Sader-Ghorra C; Sargi Z; Haddad A
J Med Liban; 2007; 55(2):83-8. PubMed ID: 17685120
[TBL] [Abstract][Full Text] [Related]
3. [Mucoepidermoid carcinomas of salivary glands: prognostic significance of immunohistochemistry. A study of 49 cases].
Santini L; Coulibaly B; Gaudart J; Turner F; Michel J; Giovanni A; Dessi P; Fakhry N
Rev Laryngol Otol Rhinol (Bord); 2012; 133(4-5):183-7. PubMed ID: 24006824
[TBL] [Abstract][Full Text] [Related]
4. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
5. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies.
Nagler RM; Kerner H; Ben-Eliezer S; Minkov I; Ben-Itzhak O
Oncology; 2003; 64(4):389-98. PubMed ID: 12759537
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands.
Yin HF; Okada N; Takagi M
Pathol Int; 2000 Aug; 50(8):603-9. PubMed ID: 10972857
[TBL] [Abstract][Full Text] [Related]
8. Mucoepidermoid carcinoma of salivary glands in children and adolescents: assessment of proliferation markers.
Hicks J; Flaitz C
Oral Oncol; 2000 Sep; 36(5):454-60. PubMed ID: 10964053
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
Monteiro LS; Bento MJ; Palmeira C; Lopes C
J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical correlation of epidermal growth factor receptor and c-erbB-2 with histopathologic grading of mucoepidermoid carcinoma.
Khiavi MM; Vosoughhosseini S; Saravani S; Halimi M
J Cancer Res Ther; 2012; 8(4):586-90. PubMed ID: 23361279
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of salivary glands.
Cardoso WP; Denardin OV; Rapoport A; Araújo VC; Carvalho MB
Sao Paulo Med J; 2000 May; 118(3):69-74. PubMed ID: 10810331
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67.
Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA
Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095
[TBL] [Abstract][Full Text] [Related]
13. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma.
Felix A; El-Naggar AK; Press MF; Ordonez NG; Fonseca I; Tucker SL; Luna MA; Batsakis JG
Hum Pathol; 1996 Jun; 27(6):561-6. PubMed ID: 8666365
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of P(53) and bcl-2 in benign and malignant salivary glands tumors.
Al-Rawi NH; Omer H; Al Kawas S
J Oral Pathol Med; 2010 Jan; 39(1):48-55. PubMed ID: 19761475
[TBL] [Abstract][Full Text] [Related]
16. Acinic cell carcinoma of minor salivary glands: a clinical and immunohistochemical study.
Triantafillidou K; Iordanidis F; Psomaderis K; Kalimeras E
J Oral Maxillofac Surg; 2010 Oct; 68(10):2489-96. PubMed ID: 20678839
[TBL] [Abstract][Full Text] [Related]
17. HER2/neu and Ki-67 as prognostic indicators in mucoepidermoid carcinoma of salivary glands.
Nguyen LH; Black MJ; Hier M; Chauvin P; Rochon L
J Otolaryngol; 2003 Oct; 32(5):328-31. PubMed ID: 14974865
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of MUC-1 has close relation with patient survivor in high-grade salivary gland mucoepidermoid carcinoma.
Siyi L; Shengwen L; Min R; Wenjun Y; Lizheng W; Chenping Z
J Oral Pathol Med; 2014 Sep; 43(8):579-84. PubMed ID: 24725122
[TBL] [Abstract][Full Text] [Related]
19. Mucoepidermoid carcinoma of minor salivary glands: a clinical study of 16 cases and review of the literature.
Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Koufogiannis D
Oral Dis; 2006 Jul; 12(4):364-70. PubMed ID: 16792720
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in primary salivary gland mucoepidermoid carcinoma: an analysis of 376 cases in an Eastern Chinese population.
Liu S; Ow A; Ruan M; Yang W; Zhang C; Wang L; Zhang C
Int J Oral Maxillofac Surg; 2014 Jun; 43(6):667-73. PubMed ID: 24568836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
